Lista de obras -

18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study

artículo científico publicado en 2017

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

artículo científico publicado en 2011

Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology

artículo científico publicado en 2009

Apolipoprotein E-ε4 increases the risk for dementia in the ‘pure’ synucleopathies

scholarly article by Debby Tsuang et al published July 2012 in Alzheimer's and Dementia

Association between cognition and function in patients with Parkinson disease with and without dementia

artículo científico publicado en 2010

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

artículo científico publicado en 2013

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease

artículo científico publicado en 2010

Biomarkers for atypical Parkinsonism: Some progress, but much work remains.

artículo científico publicado en 2018

Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials

Breaking the news: A survey of ALS patients and their caregivers

Bridging the credibility gap in cost effectiveness analysis.

artículo científico publicado en 2013

Building an integrated neurodegenerative disease database at an academic health center

artículo científico publicado en 2011

CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.

artículo científico publicado en 2018

Can a screening questionnaire accurately identify mild Parkinsonian signs?

artículo científico publicado en 2012

Cardiac denervation in rapid eye movement sleep behavior disorder and Parkinson's disease: Getting to the heart of the matter ⬇️

artículo científico publicado el 30 de octubre de 2010

Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities

artículo científico publicado en 2013

Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database

artículo científico publicado en 2013

Clinical trials with rasagiline: evidence for short-term and long-term effects

artículo científico publicado en 2006

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

artículo científico publicado en 2007

Cognition among individuals along a spectrum of increased risk for Parkinson's disease

artículo científico publicado en 2018

Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

artículo científico publicado en 2015

Cognitive impairment and PD patients' capacity to consent to research

artículo científico publicado en 2013

Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease

artículo científico publicado en 2007

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort

artículo científico publicado en 2017

Daytime sleepiness is associated with falls in Parkinson's disease

scientific article published on January 2013

Delayed Parkinson's disease diagnosis among African-Americans: the role of reporting of disability

artículo científico publicado en 2011

Design of comprehensive Alzheimer's disease centers to address unmet national needs

artículo científico publicado en 2010

Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire

artículo científico publicado en 2015

Development of quality of care indicators for Parkinson's disease

artículo científico publicado en 2004

Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease

artículo científico publicado en 2004

Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15)

artículo científico publicado en 2007

Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorder

artículo científico publicado en 2011

Disability Rating Scales in Parkinson's Disease: Critique and Recommendations

artículo científico publicado en 2016

Early retirement and income loss in patients with early and advanced Parkinson's disease.

artículo científico publicado en 2011

Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria.

artículo científico publicado en 2016

Effectiveness of Florbetapir PET Imaging in Changing Patient Management

artículo científico publicado en 2017

Everyday action impairment in Parkinson's disease dementia

artículo científico publicado en 2012

F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients

artículo científico publicado en 2008

Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study

artículo científico publicado en 2010

Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival

artículo científico publicado en 2002

Genetic influences on cognitive decline in Parkinson's disease

artículo científico publicado en 2012

Genetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest

artículo científico publicado en 2011

Health-related quality-of-life scales in Parkinson's disease: critique and recommendations

artículo científico publicado en 2011

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study

artículo científico publicado en 2014

Impairment of script comprehension in Lewy body spectrum disorders

artículo científico publicado en 2013

Impairments of speech fluency in Lewy body spectrum disorder

artículo científico publicado en 2011

Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings

Local institutional review board (IRB) review of a multicenter trial: local costs without local context

artículo científico publicado en 2010

Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease

artículo científico publicado en 2006

Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort.

artículo científico publicado en 2018

Longitudinal study of normal cognition in Parkinson disease

artículo científico publicado en 2015

Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease

artículo científico publicado en 2013

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores

artículo científico publicado en 2008

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease

artículo científico publicado en 2009

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

artículo científico publicado en 2017

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study

artículo científico publicado en 2014

Neuro-QoL health-related quality of life measurement system: Validation in Parkinson's disease

artículo científico publicado en 2016

Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsy

artículo científico publicado en 2012

Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment

artículo científico publicado en 2010

Observations on a 2-Step Approach to Screening for Parkinson Disease-Reply

artículo científico publicado en 2017

Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease ⬇️

artículo científico publicado el 15 de octubre de 2010

Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy

artículo científico publicado en 2008

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders

artículo científico publicado en 2014

Parkinson's at risk syndrome: can Parkinson's disease be predicted?

artículo científico publicado en 2010

People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance

artículo científico publicado en 2014

Piloting the NPF data-driven quality improvement initiative

artículo científico publicado en 2010

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease

artículo científico publicado en 2016

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

artículo científico publicado en 2013

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

artículo científico publicado en 2010

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

artículo científico publicado en 2012

Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline

artículo científico publicado en 2013

Preclinical diagnosis of Parkinson's disease: are we there yet?

artículo científico publicado en 2006

Premotor Parkinson's disease: clinical features and detection strategies

artículo científico publicado en 2009

Premotor Parkinson's disease: clinical features, detection, and prospects for treatment.

artículo científico publicado en 2008

Premotor Parkinson's disease: concepts and definitions

artículo científico publicado en 2012

Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference

artículo científico publicado en 2014

Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging

artículo científico publicado en 2017

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale

artículo científico publicado en 2011

Racial differences in the diagnosis of Parkinson's disease

artículo científico publicado en 2009

Rasagiline improves quality of life in patients with early Parkinson's disease

artículo científico publicado en 2006

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

artículo científico publicado en 2017

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition

artículo científico publicado en 2017

Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study

artículo científico publicado en 2013

Screening questionnaires for parkinsonism: a systematic review

artículo científico publicado en 2011

Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease

artículo científico publicado en 2010

Sentence processing in Lewy body spectrum disorder: the role of working memory

artículo científico publicado en 2012

TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia

scholarly article by Thomas F. Tropea et al published 14 May 2019 in Annals of Neurology

Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial

artículo científico publicado en 2002

The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease

artículo científico publicado en 2016

The organization of narrative discourse in Lewy body spectrum disorder

artículo científico publicado en 2011

Treatment disparities in Parkinson's disease

artículo científico publicado en 2009

Update on Parkinson disease

artículo científico publicado en 2003

Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study

artículo científico publicado en 2017

Lista de obras de

18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology

Apolipoprotein E-ε4 increases the risk for dementia in the ‘pure’ synucleopathies

Association between cognition and function in patients with Parkinson disease with and without dementia

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease

Biomarkers for atypical Parkinsonism: Some progress, but much work remains.

Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials

Breaking the news: A survey of ALS patients and their caregivers

Bridging the credibility gap in cost effectiveness analysis.

Building an integrated neurodegenerative disease database at an academic health center

CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.

Can a screening questionnaire accurately identify mild Parkinsonian signs?

Cardiac denervation in rapid eye movement sleep behavior disorder and Parkinson's disease: Getting to the heart of the matter ⬇️

Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities

Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database

Clinical trials with rasagiline: evidence for short-term and long-term effects

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

Cognition among individuals along a spectrum of increased risk for Parkinson's disease

Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

Cognitive impairment and PD patients' capacity to consent to research

Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort

Daytime sleepiness is associated with falls in Parkinson's disease

Delayed Parkinson's disease diagnosis among African-Americans: the role of reporting of disability

Design of comprehensive Alzheimer's disease centers to address unmet national needs

Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire

Development of quality of care indicators for Parkinson's disease

Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease

Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15)

Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorder

Disability Rating Scales in Parkinson's Disease: Critique and Recommendations

Early retirement and income loss in patients with early and advanced Parkinson's disease.

Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria.

Effectiveness of Florbetapir PET Imaging in Changing Patient Management

Everyday action impairment in Parkinson's disease dementia

F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients

Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study

Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival

Genetic influences on cognitive decline in Parkinson's disease

Genetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest

Health-related quality-of-life scales in Parkinson's disease: critique and recommendations

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study

Impairment of script comprehension in Lewy body spectrum disorders

Impairments of speech fluency in Lewy body spectrum disorder

Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings

Local institutional review board (IRB) review of a multicenter trial: local costs without local context

Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease

Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort.

Longitudinal study of normal cognition in Parkinson disease

Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study

Neuro-QoL health-related quality of life measurement system: Validation in Parkinson's disease

Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsy

Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment

Observations on a 2-Step Approach to Screening for Parkinson Disease-Reply

Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease ⬇️

Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders

Parkinson's at risk syndrome: can Parkinson's disease be predicted?

People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance

Piloting the NPF data-driven quality improvement initiative

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline

Preclinical diagnosis of Parkinson's disease: are we there yet?

Premotor Parkinson's disease: clinical features and detection strategies

Premotor Parkinson's disease: clinical features, detection, and prospects for treatment.

Premotor Parkinson's disease: concepts and definitions

Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference

Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale

Racial differences in the diagnosis of Parkinson's disease